Literature DB >> 28427149

Interaction between PPAR γ and SORL1 gene with Late-Onset Alzheimer's disease in Chinese Han Population.

Hui Zhang1, Wei Zheng2, Linlin Hua2, Yutong Wang3, Jinfeng Li1, Hongying Bai4, Shanshan Wang1, Mingyao Du1, Xuelian Ma1, Chunyang Xu4, Xiaodong Li4, Bin Gong1, Yunliang Wang4,1.   

Abstract

AIMS: To investigate the impact of sortilin-related receptor 1 gene 1 (SORL1) and peroxisome proliferator activated receptor gamma (PPAR G) gene single nucleotide polymorphisms (SNPs), gene- gene and gene- environment interactions and haplotype on late-onset Alzheimer's disease (LOAD) risk.
METHODS: Hardy-Weinberg equilibrium (HWE), haplotype analysis and pairwise linkage disequilibrium (LD) analysis were investigated by using SNPStats (available online at http://bioinfo.iconcologia.net/SNPstats). Logistic regression was performed to investigate association between SNPs and LOAD. Generalized multifactor dimensionality reduction (GMDR) was used to investigate the interaction among gene- gene and gene- environment interaction.
RESULTS: Logistic regression analysis showed that LOAD risk was significantly higher in carriers of the A allele of rs1784933 polymorphism than those with GG (GA+ AA versus GG), adjusted OR (95%CI) = 1.63(1.27-1.98), and higher in carriers of G allele of the rs1805192 polymorphism than those with CC (CG+ GG versus CC), adjusted OR (95%CI) = 1.70 (1.25-2.27). GMDR analysis suggested a significant two-locus model (p = 0.0010) involving rs1784933 and rs1805192, and a significant two-locus model (p = 0.0100) involving rs1784933 and alcohol drinking. Haplotype containing the rs1784933- A and rs689021- C alleles were associated with a statistically increased LOAD risk (OR = 1.86, 95%CI = 1.37- 2.52, p < 0.001).
CONCLUSIONS: We conclude that rs1784933 and rs1805192 minor alleles, gene- gene interaction between rs1784933 and rs1805192, gene- environment interaction between rs1784933 and alcohol drinking, and haplotype containing the rs1784933- A and rs689021- C alleles are all associated with increased LOAD risk.

Entities:  

Keywords:  PPAR G; SORL1; alcohol drinking; interaction; single nucleotide polymorphism

Mesh:

Substances:

Year:  2017        PMID: 28427149      PMCID: PMC5564649          DOI: 10.18632/oncotarget.15691

Source DB:  PubMed          Journal:  Oncotarget        ISSN: 1949-2553


INTRODUCTION

Alzheimer's disease (AD) was the main cause for dementia in persons with middle and old age [1], and is a complex and progressive neurodegeneration characterised by large numbers of senile plaques and neurofibrillary tangles in the brain [2]. Clinically, late-onset AD (LOAD) is more common type of AD and the heritability for susceptibility to LOAD could be 80% in previous studies [3]. The etiology and pathogenesis of LOAD are still not clear, AD was a multifactorial disease and the complex pathology was resulted by the interaction of both genetics and environmental factors, however, until recently, the only reliable risk factor, the e4 allele of apolipoprotein E (APOE) was verified. It was necessary to find and validate biomarkers for AD prevention, especially for LOAD, which has a strong genetic component [4], and several genes have been identified in the genome-wide association studies [5, 6], including the neuronal sortilin-related receptor (SORL1) [7] and peroxisome proliferator activated receptor gamma (PPAR G) gene [8]. SORL1 gene locates on chromosome 11q23.2–q24.2 [9]. Recent studies and replication studies have indicated that polymorphisms within SORL1 gene were associated with susceptibility to AD, which support the association between SNPs within SORL1 gene and AD risk [10- 13]. However, the other studies concluded controversial results, which indicated a weak or no association between SNPs in SORL1 gene and AD risk in Caucasian populations [14-16]. Recently, some studies reported that PPAR G can regulate amyloidogenic pathways [17, 18], they suggest that PPAR G may be a potential candidate gene for AD. However, results on association between PPAR G and LOAD were inconsistent yet [19, 20]. In addition, LOAD susceptibility could be influenced by both environmental and genetic factors, and their synergistic effects between gene and environment, and previous studies have suggested that alcohol drinking was an important risk factor of LOAD [21, 22]. However, till now, less study focused on gene- alcohol drinking interaction on LOAD risk. In consideration of the previous inconsistent results on association of PPAR G and SORL1 gene with LOAD, less numbers study on gene- alcohol drinking interaction and linkage disequilibrium (LD) among SNPs. In this study, we aimed to investigate the impact of PPAR G and SORL1 gene SNPs, additional gene- gene, gene- environment interaction and haplotype combination on LOAD risk.

MATERIALS AND METHODS

Participants

In this case-control study, participants were consecutively recruited between January 2009 and November 2014 from the Second Affiliated Hospital of Zhengzhou University. Clinical diagnosis of probable AD is made according to the revised criteria of National Institute of Neurological and Communicative Disorders and Stroke/ Alzheimer's Disease and Related Disorders Association (NINCDS/ ADRDA) [23], participants with advanced, severe, progressive, or unstable infectious, metabolic, immunologic, endocrinological, hepatic, hematological, pulmonary, cardiovascular, gastrointestinal, and/or urological diseases are excluded. The detailed participant selection methods have been described in our previous study [24]. Data on demographic information, mini-mental state examination (MMSE), educational year, lifestyle risk factors, smoking and drinking status, prevalence of stroke, prevalence of diabetes and family history of AD for all participants are obtained using a questionnaire administered by trained staffs. Body weight, height and waist circumference (WC) are measured, and body mass index (BMI) are calculated. Blood samples are collected in the morning after at least 8 hours of fasting. All plasma and serum samples are frozen at –80°C until laboratory testing. Plasma glucose is measured using an oxidase enzymatic method. The concentrations of HDL cholesterol and triglycerides are assessed enzymatically using an automatic biochemistry analyzer (Hitachi Inc., Tokyo, Japan) and commercial reagents.

Genomic DNA extraction and genotyping

SNPs within the SORL1 and PPAR G gene were selected according to the following methods: 1) SNPs, which have been reported associations with AD and not been well studied; 2) SNPs, the MAF of which were more than 5%. At last, three SNPs of SORL1 gene and three SNPs of PPAR G gene are selected for genotyping in the study, including: rs709158, rs1805192 and rs10865710 within PPAR G gene, rs1784933, rs3824966 and rs689021 within SORL1 gene. Genomic DNA is extracted from EDTA-treated whole blood, using the DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The genotyping methods for PPAR G gene have been described in our previous study [24]. Genotyping of three SNPs within SORL1 gene were performed using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) analysis. PCR primer sequences for each polymorphism were shown in Table 1. The PCR reactions were carried out in a final volume of 25 μl containing: 10 × PCR buffer, 4.5 mM MgCl2 (Roche, Germany), 0.4 mM of each dNTP (Fermentas, Germany), 10 pmol of each primer, 30 ng template DNA, 1 U Taq DNA polymerase (Roche, Germany) and sterile distilled water up to 25 μl. PCR conditions were: 94 °C for 15min, then 45 cycles of 94 °C for 20 s, 56 °C for 30 s, and 72 °C for 1min, with a final extension at 72 °C for 30min and then reactions held at 4 °C.
Table 1

Description and Probe sequence for 6 SNPs used for Taqman fluorescence probe analysis

SNP IDChromosomeFunctional ConsequenceMajor/ minor allelesNucleotide sequences/ Probe sequence
SORL1
rs68902111:121500411Intron variantT/CForward: ACGTTGGATGACCTTACAGATGATGCAGCCReverse: ACGTTGGATGGGCCATAGTTTCCTAGCATC
rs382496611:121577474Intron variantG/CForward: ACGTTGGATGCCAAGCTAATTCTCAGAGCCReverse: ACGTTGGATGTTGACAGCACTCATCCGTTC
rs178493311:121618707Intron variantG/AForward: ACGTTGGATGTTTGAAGCAGTTCCAGGGTCReverse: ACGTTGGATGGAATGGAAGAGGACATCAGC
PPARG
rs7091583:12421677Intron variantA/G5’-AGATACGGGGGAGGAAATTCACTGG[A/G]TTTTACAATATATTTTTCAAGGCAA-3’
rs108657103:12311699Intron variant, upstream variant 2KBC/G5’-TTGGCATTAGATGCTGTTTTGTCTT[C/G]ATGGAAAATACAGCTATTCTAGGAT-3’
rs18051923:12379739MissenseC/G5’-ACCTCAGACAGATTGTCACGGAACA[C/T]GTGCAGCTACTGCAGGTGATCAAGA-3’

Statistical analysis

The means and standard deviations (SD) were calculated for normally distributed continuous variables, and percentages were calculated for categorical variables. The categorical data were analyzed using χ2 test. Further, continuous variables were analyzed using Student's t test. Hardy-Weinberg equilibrium (HWE), haplotype analysis and pairwise LD analysis were investigated by using SNPStats (available online at http://bioinfo.iconcologia.net/SNPstats). Logistic regression was performed to investigate association between SNPs and LOAD. Generalized multifactor dimensionality reduction (GMDR) was used to investigate the interaction among gene- gene and gene- environment interaction, cross-validation consistency, the testing balanced accuracy, and the sign test, to assess each selected interaction were calculated. The cross-validation consistency score is a measure of the degree of consistency with which the selected interaction is identified as the best model among all possibilities considered. Testing-balanced accuracy is a measure of the degree to which the interaction accurately predicts case–control status, and yields a score between 0.50 (indicating that the model predicts no better than chance) and 1.00 (indicating perfect prediction). Finally, the sign test, or permutation test (providing empirical P-values), for prediction accuracy can be used to measure the significance of an identified model.

RESULTS

A total of 880 participants (514 males, 366 females) were selected, including 430 LOAD patients and 450 control subjects. The mean age of all participants was 81.7 ± 15.9 years old. Table 2 shows the general characteristics, clinical and blood biochemical index for all participants. The cases have the higher alcohol- drinking rate than controls. The means of FPG and TG were significantly higher in cases and controls, but the mean of HDL was lower in cases and controls.
Table 2

General characteristics of 880 study participants in case and control group

VariablesCase group(n= 430)Normal group(n= 450)p-values
Age (year)81.4±16.182.3±15.70.401
Males, N (%)246 (57.2)268(59.6)0.480
Smoke, N (%)151 (35.1)145(32.2)0.364
Alcohol consumption, N (%)188 (43.7)160 (35.6)0.013
WC (cm)89.2±19.887.7±19.40.257
BMI (kg/m2)25.1±8.924.8±9.10.621
FPG (mmol/L)5.8±1.65.5±1.90.012
TG (mmol/L)1.4±0.81.3± 0.70.048
TC (mmol/L)4.6±0.84.5±0.90.082
HDL (mmol/L)1.21±0.651.34±0.630.002
Stroke16 (3.72)20 (4.44)0.255
MMSE (scores)15.16±5.5129.12±4.97<0.001
Diabetes36 (8.37)43(9.56)0.539
Educational year7.5±3.127.8±3.310.167

Note: Means± standard deviation for age, WC, BMI, FPG, TC, TG, HDL-C and ANP; TC, total cholesterol; HDL, high density lipoprotein; FPG, fast plasma glucose; TG, triglyceride; WC, waist circumference; BMI, body mass index; MMSE, mini-mental state examination;

Note: Means± standard deviation for age, WC, BMI, FPG, TC, TG, HDL-C and ANP; TC, total cholesterol; HDL, high density lipoprotein; FPG, fast plasma glucose; TG, triglyceride; WC, waist circumference; BMI, body mass index; MMSE, mini-mental state examination; In Table 3, the frequencies for the rs1784933- A allele within SORL1 gene and rs1805192- G allele within PPAR G were significantly higher in LOAD cases than that in controls. The carriers with the rs1784933- A allele have higher LOAD risk than those with GG genotype (GA+ AA versus GG), adjusted OR (95%CI) = 1.63 (1.27-1.98), and the carriers with rs1805192- G allele also have higher LOAD risk than those with CC genotype (CG+ GG versus CC), adjusted OR (95%CI) = 1.70 (1.25-2.27). However, we the others SNP within SORL1 and PPAR G gene were not associated with LOAD susceptibility after covariates adjustment.
Table 3

Genotype and allele frequencies of 6 SNPs between case and control group

Gene/ SNPGenotypes and AllelesFrequencies N (%)OR(95%CI)*P- valuesHWE test for controls
Control (n=450)Case (n=430)
SORL1
rs689021Co- dominant
TT271 (60.2)235(54.6)1.000.360
TC152 (33.8)153(35.6)1.13 (0.82-1.85)0.621
CC27 (6.0)42(9.8)1.40 (0.89-1.98)0.506
Dominant
TT271 (60.2)235(54.6)1.00
TC +CC179(39.8)195 (45.4)1.19 (0.83-1.89)0.605
Allele, C (%)206(22.9)237(27.6)
rs3824966Co- dominant
GG276(61.3)243(56.5)1.000.691
GC151(33.6)156(36.3)1.27(0.95-1.71)0.236
CC23(5.1)31(7.2)1.45(0.81-2.22)0.379
Dominant
GG276(61.3)243(56.5)1.00
GC+CC174(38.7)187(43.5)1.42(0.92-1.87)0.252
Allele, C (%)197(21.9)218(25.3)
rs1784933Co- dominant0.999
GG288(64.0)198(46.1)1.00
GA144(32.0)182(42.3)1.55(1.24-1.91)<0.001
AA18(4.0)50(11.6)2.08 (1.41-2.92)<0.001
Dominant
GG288(64.0)198(46.1)1.00
GA+AA162(36.0)232(53.9)1.63(1.27-1.98)<0.001
Allele, A (%)180(20.0)282(32.8)
PPAR G
rs1805192Co- dominant0.073
CC283(62.9)212(49.3)1.00
CG139(30.9)164(38.1)1.57 (1.21-1.79)<0.001
GG28(6.2)54(12.6)2.15 (1.42-2.98)<0.001
Dominant
CC283(62.9)212(49.3)1.00
CG+GG167(37.1)218(50.7)1.70 (1.25-2.27)<0.001
Allele, G (%)195(21.7)272(31.7)
rs10865710Co- dominant0.226
CC255(56.7)234(54.4)1.00
CG161(35.8)160(37.2)1.07 (0.86-1.48)0.628
GG34(7.6)36(8.4)1.02 (0.70-1.69)0.746
Dominant
CC255(56.7)234(54.4)1.00
CG+GG195(43.4)196(45.6)1.06 (0.87-1.51)0.656
Allele, G (%)229(25.4)232(27.0)
rs709158Co- dominant
AA263(58.4)240(55.8)1.000.836
AG161(35.8)157(36.5)1.02 (0.81-1.41)0.434
GG26(5.8)33(7.7)1.11 (0.78-1.62)0.592
Dominant
AA263(58.4)240(55.8)1.00
AA+GG187(41.6)190(44.2)1.05 (0.80-1.45)0.483
Allele, G (%)213(23.7)223(25.9)

*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes.

*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes. GMDR analysis was used to investigate the impact of the interaction among 6 SNPs within SORL1 and PPAR G gene on LOAD risk. Table 4 shows a significant two-locus model (p = 0.0010) involving rs1784933 and rs1805192, and in this model, the cross- validation consistency was 9/ 10, and the testing accuracy was 62.70%. We also found a significant two-locus model (p = 0.0100) involving rs1784933 and alcohol drinking, and in this model, the cross-validation consistency was 10/ 10, and the testing accuracy was 60.72%, after covariates adjustment for alcohol consumption status, FPG, TG and HDL (Table 5).
Table 4

Best gene–gene interaction models, as identified by GMDR

Locus no.Best combinationCross-validation consistencyTesting accuracyp-values*
Gene- gene interaction
2rs1784933 rs18051929/100.62700.0010
3rs1784933 rs1805192 rs108657108/100.53990.0547
4rs1784933 rs1805192 rs10865710 rs38249667/100.53990.1719
5rs1784933 rs1805192 rs10865710 rs3824966 rs6890217/100.49580.3770
6rs1784933 rs1805192 rs10865710 rs3824966 rs689021 rs7091586/100.49580.4258
Gene- environment interaction
2rs1784933 alcohol drinking10/100.60720.0100
3rs1784933 rs1805192 alcohol drinking8/100.53990.1719
4rs1784933 rs1805192 rs10865710 alcohol drinking7/100.53990.1719
5rs1784933 rs1805192 rs10865710 rs3824966 alcohol drinking6/100.49580.4258
6rs1784933 rs1805192 rs10865710 rs3824966 rs689021 alcohol drinking5/100.49580.3770
7rs1784933 rs1805192 rs10865710 rs3824966 rs689021 rs709158 alcohol drinking6/100.49580.9893

*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes.

Table 5

The D’ values among SNPs within PPAR G and SORL1 gene for the linkage disequilibrium test

SNPsD’ values
PPAR G geners10865710rs709158
rs18051920.3620.623
rs10865710-0.482
SORL1 geners3824966rs689021
rs17849330.5480.823
rs3824966-0.617
*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes. Pairwise LD analysis between SNPs was performed and D’ values were shown in Table 5, we found that just D′ value between rs1784933 and rs689021 within SORL1 gene was 0.823, which shown a strong chain reaction. So we also conducted haplotype analysis between the two SNPs. We found that the most common haplotype in SORL1 gene was rs1784933- G and rs689021- T haplotype, the frequency of which was 0.4701 and 0.5467 in case group and control group. Haplotype containing the rs1784933- A and rs689021- C alleles were associated with a statistically increased LOAD risk (OR = 1.86, 95%CI = 1.37– 2.52, P < 0.001) (Table 6).
Table 6

Haplotype analysis on association between SORL1 gene and LOAD risk

Haplotypesrs1784933rs689021FrequenciesOR (95%CI)p-values*
Case groupControl group
H1GT0.47010.54671.00--
H2AT0.21670.21311.17 (0.84– 1.68)0.590
H3GC0.20350.19211.28 (0.92 - 1.75)0.612
H4AC0.10970.04811.86 (1.37 – 2.52)<0.001

*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes.

*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes.

DISCUSSION

In this study, we found that both the rs1784933- A allele and the rs1805192- G allele were associated with increased LOAD risk. However, we the others SNP within SORL1 and PPAR G gene were not associated with LOAD susceptibility after covariates adjustment. Some studies have focused on the association between PPAR G and AD risk, however the results on this association were inconsistent. Some studies concluded different results in Finnish [19], Japanese [25] and Asians and Caucasians population [20], these studies indicated that SNP and haplotype analyses for PPAR G gene were not significant associated with AD risk, so they conclude that PPAR G did not related with AD in the Finnish population. However, some studies also confirmed a significant association of SNPs within PPAR G with AD [17, 18]. Although this was not the first association study focused on the SNP of SORL1 polymorphism and the risk of LOAD risk, however, they also did not concluded consistent results. In 2007, Rogaeva et al [26] firstly reported an association between SNP in SORL1 gene and AD incidence. From then on, several population- based studies were conducted for other populations. Minster et al [15] suggested no association with LOAD risk in their cohort. The data by Liu et al [27] also suggested the similar results on relationship between genetic variants in SORL1 and the risk of AD. Some studies also found positive results on this association, which were similar with results obtained in current study. Kölsch et al [28] found that SORL1 gene variants were associated with increased AD risk. Bettens et al [10] also indicated a significant association between common SNP within SORL1 gene and LOAD, providing further evidence of genetic variations in SORL1 affecting susceptibility of LOAD. In a Japanese population, Kimura et al [29] found that SORL1 was genetically associated with Alzheimer disease, and the similar results were also obtained from the others studies [30- 32]. In this study, we found that LOAD risk was determined by both SORL1 and PPAR G gene, and synergistic reaction of both gene and environmental factors, so we also conducted analysis on impact of gene- gene and gene- environment interaction on LOAD risk. We found a significant gene- gene interaction involving rs1784933 and rs1805192, and a significant gene- environment interaction involving rs1784933 and alcohol drinking. Previously, several environmental risk factors have been reported, including alcohol drinking [21, 22], which was associated with LOAD in this study. Previously just one study focused on the impact of interaction between SORL1 rs2070045 polymorphism and ApoE genotype with the late-onset Alzheimer's disease, but they showed no interaction effect between ApoE 4 and any of the rs2070045 genotypes. In this study we also conducted the haplotype analysis for the rs1784933 and rs689021 within SORL1 gene, the D’ value of which was more than 0.8 (0.823), we found a haplotype containing the rs1784933- A and rs689021- C alleles were associated with a statistically increased LOAD risk. The current study has some limitations, which should be considered. Firstly, limited number of SNPs in SORL1 and PPAR G gene was included in this study, and in the future, more SNPs should be included in analysis. Secondly, more environmental factors should be included in the gene- environment analysis, not only for alcohol drinking. Thirdly, the results of interaction analysis should be checked in different population, not only in Chinese Han. In conclusion, we found that rs1784933 and rs1805192 minor alleles were associated with increased LOAD risk. We also found a significant gene- gene interaction between rs1784933 and rs1805192, gene- environment interaction between rs1784933 and alcohol drinking, and haplotype containing the rs1784933- A and rs689021- C alleles were all associated with increased LOAD risk.
  31 in total

1.  Gene- gene interaction between CYP2J2 and PPAR -γ gene on late-onset Alzheimer's disease in the eastern Chinese Han population.

Authors:  Shuang Geng; Yutong Wang; Yongmei Sun; Jinfeng Li; Honglei Yin; Zhilei Zeng; Xiaopeng Yang; Yuzhen Zhang; Yunliang Wang
Journal:  Behav Brain Res       Date:  2016-07-07       Impact factor: 3.332

Review 2.  Power and pitfalls of the genome-wide association study approach to identify genes for Alzheimer's disease.

Authors:  Richard Sherva; Lindsay A Farrer
Journal:  Curr Psychiatry Rep       Date:  2011-04       Impact factor: 5.285

3.  SORL1 is genetically associated with neuropathologically characterized late-onset Alzheimer's disease.

Authors:  Yanan Wen; Akinori Miyashita; Nobutaka Kitamura; Tamao Tsukie; Yuko Saito; Hiroyuki Hatsuta; Shigeo Murayama; Akiyoshi Kakita; Hitoshi Takahashi; Hiroyasu Akatsu; Takayuki Yamamoto; Kenji Kosaka; Haruyasu Yamaguchi; Kohei Akazawa; Yasuo Ihara; Ryozo Kuwano
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma.

Authors:  Magdalena Sastre; Ilse Dewachter; Steffen Rossner; Nenad Bogdanovic; Evan Rosen; Peter Borghgraef; Bernd O Evert; Lucia Dumitrescu-Ozimek; Dietmar R Thal; Gary Landreth; Jochen Walter; Thomas Klockgether; Fred van Leuven; Michael T Heneka
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

5.  Lack of genetic associations between PPAR-γ gene rs1801282 polymorphism and Alzheimer's disease in general population: a meta-analysis.

Authors:  Yongfu Wu; Qingyun Wu; Hanbin Zhang; Chuyan Chen; Guangzhao Chen; Huiling Yang; Dongyun Qin; Hui Fu
Journal:  Gene       Date:  2015-03-11       Impact factor: 3.688

6.  Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.

Authors:  Seppo Helisalmi; Timo Tarvainen; Saila Vepsäläinen; Anne Mari Koivisto; Mikko Hiltunen; Hilkka Soininen
Journal:  Neurosci Lett       Date:  2008-06-17       Impact factor: 3.046

7.  Role of genes and environments for explaining Alzheimer disease.

Authors:  Margaret Gatz; Chandra A Reynolds; Laura Fratiglioni; Boo Johansson; James A Mortimer; Stig Berg; Amy Fiske; Nancy L Pedersen
Journal:  Arch Gen Psychiatry       Date:  2006-02

8.  Association of SORL1 gene variants with Alzheimer's disease.

Authors:  Heike Kölsch; Frank Jessen; Jens Wiltfang; Piotr Lewczuk; Martin Dichgans; Stefan J Teipel; Johannes Kornhuber; Lutz Frölich; Isabella Heuser; Oliver Peters; Birgitt Wiese; Hanna Kaduszkiewicz; Hendrik van den Bussche; Michael Hüll; Alexander Kurz; Eckhart Rüther; Fritz A Henn; Wolfgang Maier
Journal:  Brain Res       Date:  2009-02-03       Impact factor: 3.252

9.  Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with Dementia.

Authors:  Nobuto Shibata; Yumiko Motoi; Hiroyuki Tomiyama; Tohru Ohnuma; Bolati Kuerban; Katrin Tomson; Miwa Komatsu; Hiromi Shimazaki; Nobutaka Hattori; Heii Arai
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-05-18

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  3 in total

1.  SORL1 Polymorphisms in Mexican Patients with Alzheimer's Disease.

Authors:  Danira Toral-Rios; Elizabeth Ruiz-Sánchez; Nancy Lucero Martínez Rodríguez; Marlene Maury-Rosillo; Óscar Rosas-Carrasco; Fernando Becerril-Pérez; Francisco Mena-Barranco; Rosa Carvajal-García; Daniela Silva-Adaya; Yair Delgado-Namorado; Gerardo Ramos-Palacios; Carmen Sánchez-Torres; Victoria Campos-Peña
Journal:  Genes (Basel)       Date:  2022-03-25       Impact factor: 4.141

2.  Stability in BMI over time is associated with a better cognitive trajectory in older adults.

Authors:  Michal Schnaider Beeri; Amir Tirosh; Hung-Mo Lin; Sapir Golan; Ethel Boccara; Mary Sano; Carolyn W Zhu
Journal:  Alzheimers Dement       Date:  2022-01-20       Impact factor: 16.655

3.  Endophenotypic effects of the SORL1 variant rs2298813 on regional brain volume in patients with late-onset Alzheimer's disease.

Authors:  Chun-Yu Chen; Yung-Shuan Lin; Wei-Ju Lee; Yi-Chu Liao; Yu-Shan Kuo; Albert C Yang; Jong-Ling Fuh
Journal:  Front Aging Neurosci       Date:  2022-08-05       Impact factor: 5.702

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.